Skip to main content
Erschienen in: Acta Neurologica Belgica 2/2013

01.06.2013 | Original Article

Evaluation of the retinal changes in patients with chronic migraine

verfasst von: Serkan Kirbas, Ahmet Tufekci, Kemal Turkyilmaz, Aynur Kirbas, Veysi Oner, Mustafa Durmus

Erschienen in: Acta Neurologica Belgica | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate retinal nerve fiber layer (RNFL) thickness and macular changes (central subfield thickness, cube average thickness, cube volume) in patients with chronic migraine (CM) without visual impairment using spectral-domain optical coherence tomography (SD-OCT) and to compare the results to healthy controls. A total of 80 subjects, including 40 CM patients (18 females, 12 males, at 19–36 years of age) with no migraine prophylactic treatment and 40 healthy controls (16 females, 14 males, at 20–40 years of age) were enrolled. Both eyes of patients with CM and controls were imaged using Cirrus HD SD-OCT (Carl Zeiss Meditec, Dublin, CA, USA). The average RNFL thickness was not significantly thinner in patients with CM. The mean average RNFL thickness was 83 ± 10.5 μm in CM patients and 85 ± 9.6 μm in healthy controls (p = 0.648), but superior quadrant RNFL thickness in the CM patients was significantly lower than healthy controls. The mean superior RNFL thickness was 86 ± 6.7 μm in CM patients and 108 ± 7.3 μm in controls (p < 0.001). Illness duration and frequency of the attacks were not affected by RNFL thickness. No significant differences were detected in macular changes between CM patients and healthy controls. In our study, the thickness of superior RNFL was found to be thinner in CM patients. This implies that longitudinal follow-up is needed to clarify whether RNFL thinning, in migraine patients, is related to a progressive loss of axons and retinal ganglion cells.
Literatur
1.
Zurück zum Zitat Lipton R, Bigal M, Diamond M, Freitag F, Reed M, Stewart W (2007) Migraine prevalence, disease burden and the need for preventive therapy. Neurology 68:343–349PubMedCrossRef Lipton R, Bigal M, Diamond M, Freitag F, Reed M, Stewart W (2007) Migraine prevalence, disease burden and the need for preventive therapy. Neurology 68:343–349PubMedCrossRef
2.
Zurück zum Zitat Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein SD (2012) Chronic-migraine-classification, characteristics and treatment. Nat Rev Neurol 8:162–171PubMedCrossRef Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein SD (2012) Chronic-migraine-classification, characteristics and treatment. Nat Rev Neurol 8:162–171PubMedCrossRef
3.
Zurück zum Zitat Carod-Artal FJ, Irimia P, Ezpeleta D (2012) Chronic migraine: definition, epidemiology, risk factors and treatment. Rev Neurol 54:629–637PubMed Carod-Artal FJ, Irimia P, Ezpeleta D (2012) Chronic migraine: definition, epidemiology, risk factors and treatment. Rev Neurol 54:629–637PubMed
4.
Zurück zum Zitat Kurth T, Chabriat H, Bousser MG (2012) Migraine and stroke: a complex association with clinical implications. Lancet Neurol 11:92–100PubMedCrossRef Kurth T, Chabriat H, Bousser MG (2012) Migraine and stroke: a complex association with clinical implications. Lancet Neurol 11:92–100PubMedCrossRef
5.
Zurück zum Zitat Killer HE, Forrer A, Flammer J (2003) Retinal vasospasm during an attack of migraine. Retina 23:253–254PubMedCrossRef Killer HE, Forrer A, Flammer J (2003) Retinal vasospasm during an attack of migraine. Retina 23:253–254PubMedCrossRef
6.
Zurück zum Zitat Kruit MC, Van Buchem Ma, Hofman PAM (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427–434PubMedCrossRef Kruit MC, Van Buchem Ma, Hofman PAM (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427–434PubMedCrossRef
7.
Zurück zum Zitat Tan FU, Akarsu C, Güllü R (2005) Retinal nerve fiber layer thickness is unaffected in migraine patients. Acta Neurol Scand 112:19–23PubMedCrossRef Tan FU, Akarsu C, Güllü R (2005) Retinal nerve fiber layer thickness is unaffected in migraine patients. Acta Neurol Scand 112:19–23PubMedCrossRef
8.
Zurück zum Zitat Martinez A, Proupim N, Sanchez M (2008) Retinal nerve fiber layer thickness measurements using optical coherence tomography in migraine patients. Br J Ophthalmol 92:1069–1075PubMedCrossRef Martinez A, Proupim N, Sanchez M (2008) Retinal nerve fiber layer thickness measurements using optical coherence tomography in migraine patients. Br J Ophthalmol 92:1069–1075PubMedCrossRef
9.
Zurück zum Zitat Gipponi S, Scaroni N, Venturelli E, Forbice E, Rao R, Liberini P, Padovani A, Semeraro F. Reduction in retinal nerve fiber layer thickness in migraine patients. Neurol Sci. doi:10.1007/s10072-012-1103-0 Gipponi S, Scaroni N, Venturelli E, Forbice E, Rao R, Liberini P, Padovani A, Semeraro F. Reduction in retinal nerve fiber layer thickness in migraine patients. Neurol Sci. doi:10.​1007/​s10072-012-1103-0
10.
Zurück zum Zitat Pasol J (2011) Neuro-ophthalmic disease and optical coherence tomography: glaucoma look-alikes. Curr Opin Ophthalmol 22:124–132PubMedCrossRef Pasol J (2011) Neuro-ophthalmic disease and optical coherence tomography: glaucoma look-alikes. Curr Opin Ophthalmol 22:124–132PubMedCrossRef
11.
Zurück zum Zitat Greenberg BM, Frohman E (2010) Optical coherence tomography as a potential readout in clinical trials. Ther Adv Neurol Disord 3:153–160PubMedCrossRef Greenberg BM, Frohman E (2010) Optical coherence tomography as a potential readout in clinical trials. Ther Adv Neurol Disord 3:153–160PubMedCrossRef
12.
Zurück zum Zitat Headache Classification Committee, Olesen J, Bousser MG et al (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746PubMedCrossRef Headache Classification Committee, Olesen J, Bousser MG et al (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746PubMedCrossRef
13.
Zurück zum Zitat Ahlers C, Schmidt-Erfurth U (2009) Three-dimensional high resolution OCT imaging of macular pathology. Opt Express 17:4037–4045PubMedCrossRef Ahlers C, Schmidt-Erfurth U (2009) Three-dimensional high resolution OCT imaging of macular pathology. Opt Express 17:4037–4045PubMedCrossRef
14.
Zurück zum Zitat Kara SA, Erdemoglu AK, Karadeniz MY, Altinok D (2003) Color Doppler sonography of orbital and vertebral arteries in migraineurs without aura. J Clin Ultrasound 31:308–314PubMedCrossRef Kara SA, Erdemoglu AK, Karadeniz MY, Altinok D (2003) Color Doppler sonography of orbital and vertebral arteries in migraineurs without aura. J Clin Ultrasound 31:308–314PubMedCrossRef
15.
Zurück zum Zitat Purdy RA (2011) The role of the visual system in migraine: an update. Neurol Sci 32:89–93CrossRef Purdy RA (2011) The role of the visual system in migraine: an update. Neurol Sci 32:89–93CrossRef
16.
Zurück zum Zitat Tahiri Joutei Hassani R, Dupont Monod S, Oukacha G, Mantout F, Benrabah R, Heron H, Baudoin C (2010) Acute bilateral angle-closure glaucoma induced by topiramate: contribution of Visante OCT. J Fr Ophthalmol 33:307–311CrossRef Tahiri Joutei Hassani R, Dupont Monod S, Oukacha G, Mantout F, Benrabah R, Heron H, Baudoin C (2010) Acute bilateral angle-closure glaucoma induced by topiramate: contribution of Visante OCT. J Fr Ophthalmol 33:307–311CrossRef
17.
Zurück zum Zitat Ozturk BT, Genç E, Tokgoz M, Kerimoglu H, Genc BO (2011) Ocular changes associated with topiramate. Curr Eye Res 36:47–52PubMedCrossRef Ozturk BT, Genç E, Tokgoz M, Kerimoglu H, Genc BO (2011) Ocular changes associated with topiramate. Curr Eye Res 36:47–52PubMedCrossRef
Metadaten
Titel
Evaluation of the retinal changes in patients with chronic migraine
verfasst von
Serkan Kirbas
Ahmet Tufekci
Kemal Turkyilmaz
Aynur Kirbas
Veysi Oner
Mustafa Durmus
Publikationsdatum
01.06.2013
Verlag
Springer Milan
Erschienen in
Acta Neurologica Belgica / Ausgabe 2/2013
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-012-0150-x

Weitere Artikel der Ausgabe 2/2013

Acta Neurologica Belgica 2/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.